Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
An update on immunotherapy for multiple myeloma in 2016
Ignacio Melero Bermejo et al.
Research on HDACs for multiple myeloma: studying immunological effects and resistance models
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
Monoclonal antibodies and checkpoint inhibitors for multiple myeloma